Karolinska Development AB

Karolinska Development divests its holding in Pharmanest to an investment consortium comprising Östersjöstiftelsen, Recipharm Venture Fund and Praktikerinvest

Karolinska Development implements a more prudent and representative approach to reporting the fair value of its portfolio – divestment of Pharmanest

Karolinska Development´s Annual General Meeting 2015

Karolinska Development AB (publ) – Interim Report January – March 2015

Karolinska Development – Interim Report January – March, invitation to conference call and webcast

Karolinska Development’s Annual Report 2014 has been published